J M Reymann < J M Senard < J M Shoffner

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 38.
[0-20] [0 - 20][0 - 38][20-37][20-40]

Ident.	Authors (with country if any)	Title
000F81 (2004)	P. Pollak [France] ; F. Tison ; O. Rascol ; A. Destée ; J J Péré ; J M Senard ; F. Durif ; I. Bourdeix	Clozapine in drug induced psychosis in Parkinson's disease: a randomised, placebo controlled study with open follow up.
001207 (????)	J L Montastruc [France] ; C. Brefel-Courbon ; J M Senard ; H. Bagheri ; J. Ferreira ; O. Rascol ; M. Lapeyre-Mestre	Sleep attacks and antiparkinsonian drugs: a pilot prospective pharmacoepidemiologic study.
001210 (2001)	J L Montastruc [France] ; K. Desboeuf ; M. Lapeyre-Mestre ; J M Senard ; O. Rascol ; C. Brefel-Courbon	Long-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease.
001228 (2001)	J M Senard [France] ; C. Brefel-Courbon ; O. Rascol ; J L Montastruc	Orthostatic hypotension in patients with Parkinson's disease: pathophysiology and management.
001339 (1999)	J L Montastruc [France] ; O. Rascol ; J M Senard	Treatment of Parkinson's disease should begin with a dopamine agonist.
001352 (????)	H. Bagheri [France] ; C. Damase-Michel ; M. Lapeyre-Mestre ; S. Cismondo ; D. O'Connell ; J M Senard ; O. Rascol ; J L Montastruc	A study of salivary secretion in Parkinson's disease.
001438 (1998)	O. Rascol [France] ; U. Sabatini ; C. Brefel ; N. Fabre ; S. Rai ; J M Senard ; P. Celsis ; G. Viallard ; J L Montastruc ; F. Chollet	Cortical motor overactivation in parkinsonian patients with L-dopa-induced peak-dose dyskinesia.
001446 (1998)	J L Montastruc [France] ; M. Pelat ; P. Verwaerde ; C. Brefel-Courbon ; M A Tran ; O. Blin ; O. Rascol ; J M Senard	Fluoxetine in orthostatic hypotension of Parkinson's disease: a clinical and experimental pilot study.
001454 (????)	J M Senard [France] ; J L Montastruc	[Pharmacologic approach to autonomic failure].
001463 (1997)	J M Senard [France] ; S. Raï ; M. Lapeyre-Mestre ; C. Brefel ; O. Rascol ; A. Rascol ; J L Montastruc	Prevalence of orthostatic hypotension in Parkinson's disease.
001485 (1997)	J L Montastruc [France] ; O. Rascol ; J M Senard	Glutamate antagonists and Parkinson's disease: a review of clinical data.
001493 (1997)	N. Andreu [France] ; C. Damase-Michel ; J M Senard ; O. Rascol ; J L Montastruc	A dose-ranging study of selegiline in patients with Parkinson's disease: effect of platelet monoamine oxidase activity.
001505 (1997)	O. Rascol [France] ; U. Sabatini ; N. Fabre ; C. Brefel ; I. Loubinoux ; P. Celsis ; J M Senard ; J L Montastruc ; F. Chollet	The ipsilateral cerebellar hemisphere is overactive during hand movements in akinetic parkinsonian patients.
001521 (1996)	M E Llau [France] ; G. Durrieu ; M A Tran ; J M Senard ; O. Rascol ; J L Montastruc	A study of dopaminergic sensitivity in Parkinson's disease: comparison in "de novo" and levodopa-treated patients.
001525 (1996)	J L Montastruc [France] ; O. Rascol ; J M Senard	New directions in the drug treatment of Parkinson's disease.
001533 (1996)	O. Rascol [France] ; A J Lees ; J M Senard ; Z. Pirtosek ; J L Montastruc ; D. Fuell	Ropinirole in the treatment of levodopa-induced motor fluctuations in patients with Parkinson's disease.
001557 (1996)	O. Rascol [France] ; A J Lees ; J M Senard ; Z. Pirtosek ; C. Brefel ; J L Montastruc ; D. Fuell	A placebo-controlled study of ropinirole, a new D2 agonist, in the treatment of motor fluctuations of L-DOPA-treated parkinsonian patients.
001559 (1996)	J L Montastruc [France] ; J M Senard ; O. Rascol ; A. Rascol	Autonomic nervous system dysfunction and adrenoceptor regulation in Parkinson's disease. Clinical and pharmacological consequences.
001596 (1995)	O. Rascol [France] ; U. Sabatini ; N. Fabre ; J M Senard ; M. Simonetta-Moreau ; J L Montastruc ; M. Clanet ; A. Rascol	Abnormal vestibuloocular reflex cancellation in multiple system atrophy and progressive supranuclear palsy but not in Parkinson's disease.
001608 (1995)	J L Montastruc [France] ; O. Rascol ; J M Senard ; G. Houin ; A. Rascol	Sublingual apomorphine: a new pharmacological approach in Parkinson's disease?
001617 (1994)	M E Llau [France] ; L. Nguyen ; J M Senard ; O. Rascol ; J L Montastruc	[Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance].

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/Author.i -k "J M Senard" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/Author.i  \
                -Sk "J M Senard" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Curation
   |type=    indexItem
   |index=    Author.i
   |clé=    J M Senard
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024